SJS Investment Consulting »

Keros Therapeutics shares owned by SJS Investment Consulting

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by SJS Investment Consulting from 13F filings

Historical chart of SJS Investment Consulting investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by SJS Investment Consulting consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by SJS Investment Consulting

Quarter filed Position value Share count Share price at filing
2026-03-31 $89 8 11.13
2025-12-31 $82 4 20.50

More positions owned by SJS Investment Consulting

Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Intl Core Equity (DFIC)
Dimensional Etf Trust Ultrashort Fixed (DUSB)
Vanguard Malvern Fds Core Bd Etf (VCRB)
Dimensional Etf Trust Short Duration F (DFSD)
Eli Lilly & Co. (LLY)
Apple (AAPL)
Vanguard Malvern Fds Strm Infproidx (VTIP)
American Centy Etf Tr Us Eqt Etf (AVUS)
American Centy Etf Tr Avantis Emgmkt (AVEM)
Hormel Foods Corporation (HRL)
NVIDIA Corporation (NVDA)
American Centy Etf Tr Avantis Total Eq (AVTM)
Dimensional Etf Trust World Ex Us Core (DFAX)
Dimensional Etf Trust Global Real Est (DFGR)

View all positions for SJS Investment Consulting

Top funds holding Keros Therapeutics

BlackRock
Vanguard Group
Nantahala Capital Management
Arrowstreet Capital, Limited Partnership
State Street Corporation
Vanguard Capital Management
Madison Avenue Partners
Qube Research & Technologies
OrbiMed Advisors
Jacobs Levy Equity Management
Federated Investors
Vanguard Portfolio Management
Geode Capital Management
Renaissance Technologies
Citadel Advisors

View all funds holding Keros Therapeutics